These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34686562)

  • 1. Indirect effects of the COVID-19 pandemic on people with type 2 diabetes: time to urgently move into a recovery phase.
    Vamos EP; Khunti K
    BMJ Qual Saf; 2022 Jul; 31(7):483-485. PubMed ID: 34686562
    [No Abstract]   [Full Text] [Related]  

  • 2. Disparities in Telemedicine Use for Subspecialty Diabetes Care During COVID-19 Shelter-In-Place Orders.
    Haynes SC; Kompala T; Neinstein A; Rosenthal J; Crossen S
    J Diabetes Sci Technol; 2021 Sep; 15(5):986-992. PubMed ID: 33719622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Digital Health Among People With Type 2 Diabetes Mellitus During the COVID-19 Pandemic in Japan.
    Sankoda A; Waki K; Yamaguchi S; Mieno M; Nangaku M; Yamauchi T; Ohe K
    J Diabetes Sci Technol; 2022 Jan; 16(1):256-258. PubMed ID: 34632810
    [No Abstract]   [Full Text] [Related]  

  • 4. Indirect effects of the COVID-19 pandemic on diagnosing, monitoring, and prescribing in people with diabetes and strategies for diabetes service recovery internationally.
    Rutter MK; Carr MJ; Wright AK; Kanumilli N; Milne N; Jones E; Elton P; Ceriello A; Misra A; Del Prato S; Barron E; Hambling C; Sattar N; Khunti K; Valabhji J; Feldman EL; Ashcroft DM
    Diabetes Res Clin Pract; 2024 Jun; 212():111693. PubMed ID: 38719027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of eHealth for the Care of Patients With Diabetes in Connection to the COVID-19 Pandemic.
    Jendle J
    J Diabetes Sci Technol; 2020 Jul; 14(4):739-740. PubMed ID: 32375494
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of the COVID-19 Pandemic on Primary Health Care Disease Incidence Rates: 2017 to 2020.
    Sisó-Almirall A; Kostov B; Sánchez E; Benavent-Àreu J; González de Paz L
    Ann Fam Med; 2022; 20(1):63-68. PubMed ID: 34561213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19 Pandemic on Pediatric Diabetes Mellitus.
    Shin CH
    J Korean Med Sci; 2022 Jun; 37(22):e186. PubMed ID: 35668690
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes and the COVID-19 pandemic.
    Khunti K; Valabhji J; Misra S
    Diabetologia; 2023 Feb; 66(2):255-266. PubMed ID: 36418578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guardian-Reported Impact of the COVID-19 Pandemic on the Lifestyle of Children with Diabetes Mellitus.
    Vyas V; Singh K; Pareek P; Garg MK; Didel S; Priyanka P; Goel AD; Misra S
    J Trop Pediatr; 2022 Feb; 68(2):. PubMed ID: 35137217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic.
    Kow CS; Hasan SS
    Obes Surg; 2021 Jan; 31(1):413-414. PubMed ID: 32583299
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter to the editor in response to: Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.
    Vaishya R; Bahl S; Singh RP
    Diabetes Metab Syndr; 2020; 14(4):687-688. PubMed ID: 32442918
    [No Abstract]   [Full Text] [Related]  

  • 12. Teleconsultation and Diabetes Care Amid COVID-19 Pandemic in India: Scopes and Challenges.
    Banerjee M; Chakraborty S; Pal R
    J Diabetes Sci Technol; 2020 Jul; 14(4):714-715. PubMed ID: 32438820
    [No Abstract]   [Full Text] [Related]  

  • 13. Telemedicine for Diabetes After the COVID-19 Pandemic: We Can't Put the Toothpaste Back in the Tube or Turn Back the Clock.
    Klonoff DC
    J Diabetes Sci Technol; 2020 Jul; 14(4):741-742. PubMed ID: 32506942
    [No Abstract]   [Full Text] [Related]  

  • 14. Telehealth for Diabetes Care During Coronavirus Disease 2019 Pandemic.
    Porntharukchareon T; Worawichawong S; Tawinprai K
    Asia Pac J Public Health; 2022 May; 34(4):459-462. PubMed ID: 35255726
    [No Abstract]   [Full Text] [Related]  

  • 15. Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic.
    Ghosh A; Dutta K; Tyagi K; Gupta R; Misra A
    Diabetes Metab Syndr; 2020; 14(4):577-578. PubMed ID: 32416526
    [No Abstract]   [Full Text] [Related]  

  • 16. The coronavirus disease 2019 pandemic: telemedicine in elderly patients with type 2 diabetes.
    Fatyga E; Dzięgielewska-Gęsiak S; Wierzgoń A; Stołtny D; Muc-Wierzgoń M
    Pol Arch Intern Med; 2020 May; 130(5):452-454. PubMed ID: 32385978
    [No Abstract]   [Full Text] [Related]  

  • 17. [Impact of COVID-19 on telemedicine in diabetes management: the Belgian experience].
    Radermecker RP
    Rev Med Suisse; 2022 Aug; 18(792):1552-1555. PubMed ID: 36004655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustainable diabetes care services during COVID-19 pandemic.
    Alromaihi D; Alamuddin N; George S
    Diabetes Res Clin Pract; 2020 Aug; 166():108298. PubMed ID: 32623031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Important Changes that May Affect Telehealth Policy During the COVID-19 Pandemic.
    Yarbrough C
    Diabetes Technol Ther; 2021 Feb; 23(2):155. PubMed ID: 32870710
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetes care during COVID 19: Experience in telemedicine from a developing country.
    García-Villasante E; Baca-Carrasco V; Gutierrez-Ortiz C; Pinedo-Torres I
    Diabetes Metab Syndr; 2020; 14(5):1519. PubMed ID: 32795744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.